false
Catalog
The Liver Meeting 2019
Management of Coagulopathy in Cirrhosis
Management of Coagulopathy in Cirrhosis
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video transcript, a medical professional discusses the approach to managing liver disease patients undergoing procedures like paracentesis, liver biopsy, and endoscopy. They emphasize the limitations of using INR as a predictor of bleeding risk and highlight the importance of factors like platelet count and fibrinogen levels. The transcript touches on studies showing low bleeding rates in these procedures despite abnormal coagulation parameters in cirrhosis patients. They also mention the potential use of viscoelastic testing like thromboelastography to guide transfusion decisions. Ultimately, the speaker shares a case study of managing a patient with hepatitis C-related cirrhosis for an outpatient procedure and advocates for a personalized and evidence-based approach to procedural management in liver disease patients.
Asset Caption
Presenter: Patrick Grant
Keywords
liver disease
procedures
bleeding risk
cirrhosis patients
viscoelastic testing
evidence-based approach
×
Please select your language
1
English